Information Provided By:
Fly News Breaks for February 11, 2016
MYL
Feb 11, 2016 | 07:47 EDT
JPMorgan analyst Chris Schott sees strategic merit to Mylan's acquisition of Meda and an "attractive setup" for the company over time. He understands the selloff in the shares today, however, given the "high premium" paid for Meda and "disappointing" Q4 results. Schott keeps an Overweight rating on Mylan with a $62 price target.
News For MYL From the Last 2 Days
There are no results for your query MYL